Analyst Research Consensus on Intercept Pharmaceuticals, Inc. (NASDAQ:ICPT) and Bellicum Pharmaceuticals, Inc. (NASDAQ:BLCM)

Brokerage firms currently have a positive stance on shares of Intercept Pharmaceuticals, Inc. (NASDAQ:ICPT). The majority of analysts covering the equity have either a Buy or Strong Buy recommendation on the stock, yielding a consensus score of 2.20. Those same analysts are projecting that the stock will reach $189.75 on a short term basis.

Intercept Pharmaceuticals, Inc. (NASDAQ:ICPT) shares typically trade an average volume of 572.30 and institutions hold 87.60% of the total shares.  

MOVING AVERAGES

We see here that the stock is -13.01% away from the 20-Day Simple Moving Average.  Their 50-Day Simple Moving Average is a difference of -17.15% from current levels.  Further back, their 200-Day Simple Moving Average is -17.27% difference from today’s price.  Currently, the stock is -30.02% from its 50-Day High and 10.48% from the 50-day low. 

Intercept Pharmaceuticals, Inc. (NASDAQ:ICPT)‘s stock has performed at -12.67%.  Breaking that down further, it has performed -18.84% for the week, -10.04% for the month, -19.86% over the last quarter, -24.24% for the past half-year and -37.95% for this last year. 

Equity Research firms currently have a positive stance on shares of Bellicum Pharmaceuticals, Inc. (NASDAQ:BLCM). The majority of analysts covering the equity have either a Buy or Strong Buy recommendation on the stock, yielding a consensus score of 1.40. This is based on the research brokerage reports taken into consideration by Thomson Reuters. Those same analysts are projecting that the stock will reach $24.29 on a short term basis.

Bellicum Pharmaceuticals, Inc. (NASDAQ:BLCM)’s shares may have a significant upside to the consensus target of 24.29, but how has it been performing relative to the market?  The stock’s price is 11.72 and their relative strength index (RSI) stands at 65.78.  RSI is a technical oscillator that shows price strength by comparing upward and downward movements.  It indicates oversold and overbought price levels for a stock.  

Bellicum Pharmaceuticals, Inc. (NASDAQ:BLCM) shares are moving 8.52% trading at $11.72 today.

Leave a Comment